共 50 条
- [21] Safety and Immunogenicity of Inactivated Poliovirus Vaccine Made From Sabin Strains: A Phase II, Randomized, Positive-Controlled TrialJOURNAL OF INFECTIOUS DISEASES, 2012, 205 (02): : 237 - 243Liao, Guoyang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China Peking Union Med Coll, Kunming 650118, Peoples R China Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R ChinaLi, Rongcheng论文数: 0 引用数: 0 h-index: 0机构: Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R ChinaLi, Changgui论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R ChinaSun, Mingbo论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China Peking Union Med Coll, Kunming 650118, Peoples R China Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R ChinaLi, Yanping论文数: 0 引用数: 0 h-index: 0机构: Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R ChinaChu, Jiayou论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China Peking Union Med Coll, Kunming 650118, Peoples R China Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R ChinaJiang, Shude论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China Peking Union Med Coll, Kunming 650118, Peoples R China Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R ChinaLi, Qihan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China Peking Union Med Coll, Kunming 650118, Peoples R China Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China
- [22] A phase II, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccineHUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (11) : 2641 - 2648Tang, Rong论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R ChinaLi, Guifan论文数: 0 引用数: 0 h-index: 0机构: Beijing Minhai Biotechnol Co Ltd, Dept Registrat, Beijing, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R ChinaZhang, Chengfu论文数: 0 引用数: 0 h-index: 0机构: Lianshui Cty Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Lianshui, Jiangsu, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R ChinaZhi, Hengkui论文数: 0 引用数: 0 h-index: 0机构: Dafeng Cty Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Dafeng, Jiangsu, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R ChinaZhu, Jiahong论文数: 0 引用数: 0 h-index: 0机构: Lianshui Cty Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Lianshui, Jiangsu, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R ChinaWang, Jianjun论文数: 0 引用数: 0 h-index: 0机构: Dafeng Cty Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Dafeng, Jiangsu, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R ChinaLiang, Qi论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R ChinaHu, Yuemei论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R ChinaLi, Changgui论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Div Resp Virus Vaccines, Beijing, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Publ Hlth Res Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China
- [23] Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants A Randomized Double-Blind Placebo-Controlled StudyPEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (02) : 105 - 110Englund, Janet A.论文数: 0 引用数: 0 h-index: 0机构: Univ Washington, Childrens Hosp Res Inst, Div Infect Dis, Dept Pediat, Seattle, WA 98195 USA Univ Washington, Childrens Hosp Res Inst, Div Infect Dis, Dept Pediat, Seattle, WA 98195 USAWalter, Emmanuel论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA Univ Washington, Childrens Hosp Res Inst, Div Infect Dis, Dept Pediat, Seattle, WA 98195 USABlack, Steven论文数: 0 引用数: 0 h-index: 0机构: Cincinnati Childrens Hosp, Ctr Global Child Hlth, Cincinnati, OH USA Univ Washington, Childrens Hosp Res Inst, Div Infect Dis, Dept Pediat, Seattle, WA 98195 USABlatter, Mark论文数: 0 引用数: 0 h-index: 0机构: Primary Phys Res, Pittsburgh, PA USA Univ Washington, Childrens Hosp Res Inst, Div Infect Dis, Dept Pediat, Seattle, WA 98195 USANyberg, Jack论文数: 0 引用数: 0 h-index: 0机构: Sanofi Pasteur, Sci & Med Affairs, Swiftwater, PA USA Univ Washington, Childrens Hosp Res Inst, Div Infect Dis, Dept Pediat, Seattle, WA 98195 USARuben, Frederick L.论文数: 0 引用数: 0 h-index: 0机构: Sanofi Pasteur, Sci & Med Affairs, Swiftwater, PA USA Univ Washington, Childrens Hosp Res Inst, Div Infect Dis, Dept Pediat, Seattle, WA 98195 USADecker, Michael D.论文数: 0 引用数: 0 h-index: 0机构: Sanofi Pasteur, Sci & Med Affairs, Swiftwater, PA USA Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA Univ Washington, Childrens Hosp Res Inst, Div Infect Dis, Dept Pediat, Seattle, WA 98195 USA
- [24] A randomized, double-blinded Phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adultsJOURNAL OF TRAVEL MEDICINE, 2024, 31 (02)Mcmahon, Robert论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaFuchs, Ulrike论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaSchneider, Martina论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaHadl, Sandra论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaHochreiter, Romana论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaBitzer, Annegret论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaKosulin, Karin论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Walter Reed Army Inst Res, Bethesda, MD USA Valneva Austria GmbH, A-1030 Vienna, AustriaKoren, Michael论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, AustriaMader, Robert论文数: 0 引用数: 0 h-index: 0机构: CRETA GmbH, Campus Vienna Bioctr 3, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaZoihsl, Oliver论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaWressnigg, Nina论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaDubischar, Katrin论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaBuerger, Vera论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaEder-Lingelbach, Susanne论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, AustriaJaramillo, Juan Carlos论文数: 0 引用数: 0 h-index: 0机构: Valneva Austria GmbH, A-1030 Vienna, Austria Valneva Austria GmbH, A-1030 Vienna, Austria
- [25] Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy AdultsJOURNAL OF INFECTIOUS DISEASES, 2019, 220 (07): : 1127 - 1135Halperin, Scott A.论文数: 0 引用数: 0 h-index: 0机构: Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, Canada Nova Scotia Hlth Author, Halifax, NS, Canada Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, CanadaDas, Rituparna论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, CanadaOnorato, Matthew T.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, CanadaLiu, Kenneth论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, CanadaMartin, Jason论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, CanadaGrant-Klein, Rebecca J.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, CanadaNichols, Rick论文数: 0 引用数: 0 h-index: 0机构: NewLink Genet Inc, BioProtect Syst, Ames, IA USA Crozet Biopharma LLC, Devens, MA USA Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, CanadaColler, Beth-Ann论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, CanadaHelmond, Frans A.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, CanadaSimon, Jakub K.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, 5850-5980 Univ Ave, Halifax, NS, Canada
- [26] A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in LithuaniaJOURNAL OF INFECTIOUS DISEASES, 2021, 223 (01): : 119 - 127Bandyopadhyay, Ananda S.论文数: 0 引用数: 0 h-index: 0机构: Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USA Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USAGast, Chris论文数: 0 引用数: 0 h-index: 0机构: Biostat Consulting, Washington, DC USA Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USABrickley, Elizabeth B.论文数: 0 引用数: 0 h-index: 0机构: London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USARuttimann, Ricardo论文数: 0 引用数: 0 h-index: 0机构: Fighting Infect Dis Emerging Countries, Miami, FL USA Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USAClemens, Ralf论文数: 0 引用数: 0 h-index: 0机构: Global Res Infect Dis, Rio De Janeiro, Brazil Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USAOberste, M. Steven论文数: 0 引用数: 0 h-index: 0机构: Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USAWeldon, William C.论文数: 0 引用数: 0 h-index: 0机构: Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USAAckerman, Margaret E.论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USAConnor, Ruth, I论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Dept Pediat, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USAWieland-Alter, Wendy F.论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Dept Pediat, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USAWright, Peter论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Dept Pediat, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USAUsonis, Vytautas论文数: 0 引用数: 0 h-index: 0机构: Vilnius Univ, Fac Med, Inst Clin Med, Clin Childrens Dis, Vilnius, Lithuania Bill & Melinda Gates Fdn, 1432 Elliott Ave W, Seattle, WA 98119 USA
- [27] Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless StudyJOURNAL OF INFECTIOUS DISEASES, 2022, 226 (02): : 308 - 318Capeding, Maria Rosario论文数: 0 引用数: 0 h-index: 0机构: Res Inst Trop Med, Dept Microbiol, Muntinlupa, Philippines Res Inst Trop Med, Dept Microbiol, Muntinlupa, PhilippinesGomez-Go, Grace Devota论文数: 0 引用数: 0 h-index: 0机构: Mary Chiles Gen Hosp, Dept Pediat, Manila, Philippines Res Inst Trop Med, Dept Microbiol, Muntinlupa, PhilippinesOberdorfer, Peninnah论文数: 0 引用数: 0 h-index: 0机构: Chiang Mai Univ, Fac Med, Dept Pediat, Div Pediat Infect Dis, Chiang Mai, Thailand Res Inst Trop Med, Dept Microbiol, Muntinlupa, PhilippinesBorja-Tabora, Charissa论文数: 0 引用数: 0 h-index: 0机构: Res Inst Trop Med, Clin Res Div, Muntinlupa, Philippines Res Inst Trop Med, Dept Microbiol, Muntinlupa, PhilippinesBravo, Lulu论文数: 0 引用数: 0 h-index: 0机构: Univ Philippines Manila, Dept Pediat, Manila, Philippines Res Inst Trop Med, Dept Microbiol, Muntinlupa, PhilippinesCarlos, Josefina论文数: 0 引用数: 0 h-index: 0机构: Univ East Ramon, Coll Med, Dept Pediat, Magsaysay Mem Med Ctr, Quezon City, Philippines Res Inst Trop Med, Dept Microbiol, Muntinlupa, Philippines论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Yang, Yunjeong论文数: 0 引用数: 0 h-index: 0机构: LG Chem Ltd, Life Sci, Seoul, South Korea Res Inst Trop Med, Dept Microbiol, Muntinlupa, PhilippinesHan, Song论文数: 0 引用数: 0 h-index: 0机构: LG Chem Ltd, Life Sci, Seoul, South Korea Res Inst Trop Med, Dept Microbiol, Muntinlupa, PhilippinesWittawatmongkol, Orasri论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Fac Med, Dept Pediat, Siriraj Hosp, 2 Wanglang Rd, Bangkok 10700, Thailand Res Inst Trop Med, Dept Microbiol, Muntinlupa, Philippines
- [28] Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged >50 years: A randomized phase 3 trial (PNEU-TRUE)VACCINE, 2022, 40 (09) : 1342 - 1351Simon, Jakub K.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Merck & Co Inc, Kenilworth, NJ USAStaerke, Nina Breinholt论文数: 0 引用数: 0 h-index: 0机构: Aarhus Univ Hosp, Aarhus, Denmark Merck & Co Inc, Kenilworth, NJ USAHemming-Harlo, Maria论文数: 0 引用数: 0 h-index: 0机构: Tampere Univ, Vaccine Res Ctr, Tampere, Finland Merck & Co Inc, Kenilworth, NJ USALayle, Stacey论文数: 0 引用数: 0 h-index: 0机构: Artemis Inst Clin Res, San Diego, CA USA Merck & Co Inc, Kenilworth, NJ USA论文数: 引用数: h-index:机构:Shekar, Tulin论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Merck & Co Inc, Kenilworth, NJ USAPedley, Alison论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Merck & Co Inc, Kenilworth, NJ USAJumes, Patricia论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Merck & Co Inc, Kenilworth, NJ USATamms, Gretchen论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Merck & Co Inc, Kenilworth, NJ USASterling, Tina论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Merck & Co Inc, Kenilworth, NJ USAMusey, Luwy论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Merck & Co Inc, Kenilworth, NJ USABuchwald, Ulrike K.论文数: 0 引用数: 0 h-index: 0机构: Merck & Co Inc, Kenilworth, NJ USA Merck & Co Inc, Kenilworth, NJ USA
- [29] Immunogenicity, safety and consistency of seven lots of an inactivated COVID-19 vaccine in healthy children and adolescents: a randomized, double-blind, controlled, phase IV clinical trialFRONTIERS IN IMMUNOLOGY, 2024, 14Hu, Weijun论文数: 0 引用数: 0 h-index: 0机构: Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaLiu, Xiaoyu论文数: 0 引用数: 0 h-index: 0机构: Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaLu, Xi论文数: 0 引用数: 0 h-index: 0机构: Sinovac Biotech Co Ltd, Med Affairs Dept, Beijing, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaZhang, Dan论文数: 0 引用数: 0 h-index: 0机构: Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaLiu, Shuo论文数: 0 引用数: 0 h-index: 0机构: Sinovac Biotech Co Ltd, Clin Res & Dev Ctr, Beijing, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaGu, Xianjin论文数: 0 引用数: 0 h-index: 0机构: Yanliang Dist Ctr Dis Control & Prevent, Dept Immunizat Program, Xian, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaLiu, Dan论文数: 0 引用数: 0 h-index: 0机构: Yanliang Dist Ctr Dis Control & Prevent, Dept Immunizat Program, Xian, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaSun, Jianwen论文数: 0 引用数: 0 h-index: 0机构: Sinovac Life Sci Co Ltd, Med Affairs Dept, Beijing, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaZhou, Tiantian论文数: 0 引用数: 0 h-index: 0机构: Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaLi, Xinge论文数: 0 引用数: 0 h-index: 0机构: Sinovac Biotech Co Ltd, Clin Res & Dev Ctr, Beijing, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaGao, Yongjun论文数: 0 引用数: 0 h-index: 0机构: Sinovac Biotech Co Ltd, Med Affairs Dept, Beijing, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaZhao, Yanwei论文数: 0 引用数: 0 h-index: 0机构: Sinovac Life Sci Co Ltd, Med Affairs Dept, Beijing, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaCui, Guoliang论文数: 0 引用数: 0 h-index: 0机构: Sinovac Life Sci Co Ltd, Qual Assurance Dept, Beijing, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R ChinaZhang, Shaobai论文数: 0 引用数: 0 h-index: 0机构: Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R China Shaanxi Prov Ctr Dis Control & Prevent, Inst Immunizat Program, Xian, Peoples R China
- [30] Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trialFRONTIERS IN IMMUNOLOGY, 2023, 14Hu, Jialei论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R ChinaLiu, Yueyue论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod Control, Div Resp Virus Vaccines, Beijing, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R ChinaLiu, Shuo论文数: 0 引用数: 0 h-index: 0机构: Sinovac Biotech Co Ltd, Clin Res & Dev Ctr, Beijing, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R ChinaShu, Qun论文数: 0 引用数: 0 h-index: 0机构: Beijing Key Tech Stat Technol Co Ltd, Stat & Decis Sci, Beijing, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R ChinaYang, Xuenan论文数: 0 引用数: 0 h-index: 0机构: Sinovac Biotech Co Ltd, Clin Res & Dev Ctr, Beijing, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R ChinaChu, Kai论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R ChinaQiao, Yaping论文数: 0 引用数: 0 h-index: 0机构: Sinovac Biotech Co Ltd, Clin Res & Dev Ctr, Beijing, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R ChinaHu, Yaling论文数: 0 引用数: 0 h-index: 0机构: Sinovac Life Sci Co Ltd, Ctr Res & Dev, Beijing, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R ChinaWang, Kaiqin论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control, Inst Biol Prod Control, Div Resp Virus Vaccines, Beijing, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R ChinaPan, Hongxing论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R China Jiangsu Prov Ctr Dis Control & Prevent, Dept Vaccine Clin Evaluat, Nanjing, Jiangsu, Peoples R China